Abstract:Michael Hewetson, Rose Tallon Department of Clinical Science and Services, The Royal Veterinary College, North Mymms, Hertfordshire, UK Correspondence: Michael Hewetson Department of Clinical Science and Services, The Royal Veterinary College, North Mymms, Herts, AL9 7TA, UK Email This narrative review explores the etiopathogenesis, clinical signs, diagnosis and treatment of ESGD (equine squamous gastric disease) and discusses the impact of this commonly encountered condition on the equine industry. ESGD refers specifically to peptic injury of the squamous mucosa of the stomach. Prevalence is highest in performance horses, but the disease has been documented across many breeds and ages, including in feral horses and foals. The pathogenesis of ESGD is well understood. Intensive management and exercise are important factors that contribute to a disruption of the normal stratification of gastric pH. This results in exposure of the vulnerable squamous mucosa to acid, leading to ulceration. Clinical signs are variable and there is little evidence to support a direct association between reported signs and the presence or absence of lesions seen on gastroscopy. Management is aimed at acid suppression and mitigation of known risk factors. Keywords: ulcer, stomach, ESGD, omeprazole, performance Equine Gastric Ulcer Syndrome (EGUS) is a term that was first adopted in 1999 to describe erosive and ulcerative diseases of the equine stomach and is comparable to the term peptic ulcer disease in people. The terminology was recently expanded to include the terms Equine Squamous Gastric Disease (ESGD) and Equine Glandular Gastric Disease (EGGD) as it became clear there was a need to distinguish the anatomical region of the stomach affected. 1,2 Although squamous and glandular gastric diseases can occur concurrently, there are significant differences in prevalence, epidemiology, pathogenesis, and treatment, and they should be seen as distinct disease entities. There is currently no clear relationship between the presence of ESGD and EGGD, and direct extrapolation from one disease to another is therefore inappropriate. ESGD refers specifically to peptic injury of the squamous mucosa of the stomach and is the focus of this review. The horse is a monogastric animal, and the stomach is comprised of four distinct anatomical regions; the dorsal fundus, the ventral fundus, the cardia and the pylorus (Figure 1). The mucosal lining is divided into a dorsal squamous and a ventral glandular portion by the margo plicatus . The dorsal squamous portion has a smooth, glistening surface and is pale yellow to white in color. It is comprised of stratified squamous epithelium and is contiguous with the esophagus at the level of the cardia. Histologically, the squamous epithelium consists of layers of keratinized and non-keratinized epithelial cells, an underlying lamina propria and a muscularis mucosa. The epithelium varies in thickness from 309μm to 1154μm, and is thickest immediately adjacent to the margo plicatus , presumably as an adaptation to increased acid exposure in this region. 3 There is no inflammatory cell infiltration in the epithelium or the lamina propria of healthy equine squamous epithelium. 3 Figure 1 The normal equine stomach showing the four distinct anatomical regions. A , ventral fundus, B , cardia; C , pylorus; D , dorsal fundus. Image adapted with permission of Equine Veterinary Journal. Martineau H, Thompson H, Taylor D. Pathology of gastritis and gastric ulceration in the horse. Part 1: range of lesions present in 21 mature individuals. Equine Vet J. 2009;41(7):638–644. 23 The squamous mucosa has no absorptive or secretory capacity and simply acts as a protective barrier. In contrast, the glandular mucosa is comprised of mucus producing cells and gastric glands and is responsible for secreting hydrochloric acid (HCL) in response to gastrin. Horses are basal acid secretion and as such, they secrete acid constantly irrespective of feed consumption. 4 The pH in the ventral stomach of adult horses is therefore predominately acidic and remains relatively stable, with a median pH of 2.9 over a 24-hour period. 5 In contrast, pH in the dorsal stomach is less acidic, with a median pH of 6.8, however it is exposed to large diurnal fluctuations, likely due to the natural feeding patterns of horses. Horses consume most of their roughage during the day. 6 Once ingested, it forms a fibrous mat within the stomach that helps maintain normal pH stratification of gastric content, thereby facilitating buffering of acid in the dorsal stomach. 7 As a consequence, horses have a significantly higher pH in the dorsal stomach during t -Abstract Truncated-

Changes in saliva analytes in equine gastric ulcer syndrome (EGUS) after treatment: a pilot study

Changes in Immunoglobulins G and A in the Saliva and Serum of Horses with Equine Gastric Ulcer Syndrome (EGUS) and Their Relationship with Other Immune and Redox Status Biomarkers

Automated Spectrophotometric Assays for the Measurement of Ammonia and Bicarbonate in Saliva of Horses: Analytical Validation and Changes in Equine Gastric Ulcer Syndrome (EGUS)

Measurement of Trace Elements (Zinc, Copper, Magnesium, and Iron) in the Saliva of Horses: Validation Data and Changes in Equine Gastric Ulcer Syndrome (EGUS)

Effects of a dietary supplement on gastric ulcer number and severity in exercising horses1

Field study examining the mucosal microbiome in equine glandular gastric disease

Evaluation of the effects of medium‐term (57‐day) omeprazole administration and of omeprazole discontinuation on serum gastrin and serum chromogranin A concentrations in the horse

A study investigating the treatment of equine squamous gastric disease with long‐acting injectable or oral omeprazole

Proteomic and N-glycoproteomic quantification reveal aberrant changes in the human saliva of oral ulcer patients.

Saliva as a Potential Source of Biomarkers in Cows with Metritis: A Pilot Study

Equine Gastric Ulcer Syndrome: An Update on Current Knowledge

Evaluation of the treatment of equine glandular gastric disease with either long‐acting‐injectable or oral omeprazole

Biochemical changes in saliva of cows with inflammation: A pilot study

Equine Squamous Gastric Disease: Prevalence, Impact and Management

Changes in salivary analytes in cows due to the in vitro presence of feed

Horse Grimace Scale Does Not Detect Pain in Horses with Equine Gastric Ulcer Syndrome

The effect of feeding a commercial feedstuff on gastric squamous gastric disease (ESGD) healing and prevention of recurrence.

Therapeutic efficacy of “Omeprazole” in horses with equine gastric ulcer syndrome

Arterial Blood Gas, Electrolyte and Acid-Base Values as Diagnostic and Prognostic Indicators in Equine Colic

Plasma concentration of serum amyloid A and lipopolysaccharide binding protein in horses with laminitis resulted from hindgut acidosis

Investigating the gastrointestinal physiology of mature horses with and without a history of cribbing behavior in response to feeding a digestive support supplement